Why the study?
Long-term survival is uncommon in patients with giant retroperitoneal liposarcoma, necessitating an optimized management program to improve diagnosis, therapy, and outcomes.
Does complete surgical resection improve survival in a patient with multiple-recurrent giant retroperitoneal dedifferentiated liposarcoma?
Does complete surgical resection improve survival in a patient with multiple-recurrent giant retroperitoneal dedifferentiated liposarcoma?
Long-term survival (15 years) can be achieved in high-grade retroperitoneal dedifferentiated liposarcoma with meticulous surgical management despite multiple recurrences.
May guide individualized re-resection in recurrent giant RPLS; leaves open standardized protocols from larger cohorts.
Background: Retroperitoneal liposarcoma (RPLS) is a variety of soft tissue sarcoma that originates from mesenchymal cells. A tumor measuring greater than 30 cm is called a "giant liposarcoma." A part of the neoplasm tends to grow in size, recur locally, or metastasize distantly. In those with such a condition, long-term survival is uncommon. Therefore, it is necessary to present a uniform and optimized program to improve the prognosis. Methods: By successfully treating a multiple-recurrent giant retroperitoneal dedifferentiated liposarcoma (RP DDLPS) in July 2010, we hope to devise more comprehensive strategies to improve diagnosis, therapy, and outcome. Results: In July 2010, we thoroughly resected a giant multifocal RPLS with a concomitant part of the gastric wall. The histopathological examination revealed a high-grade (grade III) dedifferentiated liposarcoma. The patient was discharged uneventfully on the 15th postoperative day. She relapsed after 16 months and needed another complete excision. After 9 months, she died after the fourth recidive. The patient had experienced four recurrences and underwent operations with 15 years of follow-up. Conclusions: The above demonstrates that we were able to successfully treat the multirecurrent giant RPLS, despite the patient's poor medical condition, with meticulous management. Moreover, this indicates that long-term survival could be achieved for high-grade RP DDLPS.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: